Author:
Andersen Karl,Hartman Daniel,Peppard Thomas,Hermann David,Van Ess Peter,Lefkowitz Martin,Trapani Angelo
Subject
Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference12 articles.
1. The incidence and implications of aldosterone breakthrough;Bomback;Nat Clin Pract Nephrol.,2007
2. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure;Chobanian;Hypertension,2003
3. 2007 Guidelines for the management of arterial hypertension;Mancia;J Hypertens,2007
4. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators;Pitt;N Engl J Med,1999
5. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction;Pitt;N Engl J Med,2003
Cited by
46 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Safety and efficacy of once-daily dexfadrostat phosphate in patients with primary aldosteronism: a randomised, parallel group, multicentre, phase 2 trial;eClinicalMedicine;2024-05
2. Aldosterone synthase inhibitor (BI 690517) therapy for people with diabetes and albuminuric chronic kidney disease: A multicentre, randomized, double‐blind, placebo‐controlled, Phase I trial;Diabetes, Obesity and Metabolism;2024-03-18
3. Evidence for the druggability of aldosterone targets in heart failure: A bioinformatics and data science-driven decision-making approach;Computers in Biology and Medicine;2024-03
4. Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial;The Lancet;2024-01
5. Deciphering the Relationship between Salivary Cortisol Levels and Hypertension Using Enzyme-linked Immunosorbent Assay – An Observational Study;Journal of Nature and Science of Medicine;2024-01